Company Realigns into Two Business Segments — Diagnostics and Discovery & Analytical Solutions — to Further Accelerate Growth and Create Greater Customer Value

WALTHAM, Mass.– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced organizational changes effective October 3, 2016 to better position PerkinElmer to grow in attractive end markets and expand share with the Company’s core product offerings through an improved customer focus, more value-add collaboration and breakthrough innovations.

PerkinElmer’s Diagnostics business, focused on reproductive health, emerging market diagnostic solutions and applied genomics, will become a standalone business segment to better meet the needs of clinically-oriented customers in regulated markets. Prahlad Singh, who has been named Senior Vice President and President, Diagnostics effective October 3, 2016, will lead this business.

PerkinElmer’s Environmental Health and Life Science Solutio